← Back to Search

Behavioural Intervention

Bright Light Therapy for Crohn's Disease

N/A
Recruiting
Led By Netanel Zilberstein
Research Sponsored by Rush University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 15 weeks

Summary

This trial evaluates whether light therapy can help people with IBD reduce inflammation, improve gut health and improve quality of life. FDA-approved device will be used and participants will wear a watch-like device to monitor their condition.

Who is the study for?
This trial is for adults with Crohn's or Ulcerative Colitis who have stable inflammatory markers and have been on consistent medication for their condition. It excludes those with active IBD, major organ disease, recent night shift work or extensive travel, certain eye diseases, severe depression, sleep apnea, restless leg syndrome, or use of drugs affecting intestinal permeability.
What is being tested?
The study tests if bright light therapy in the morning can help people with Crohn's Disease by reducing gut inflammation and improving quality of life compared to a placebo device. Participants will switch between the real treatment and placebo at some point during the trial.
What are the potential side effects?
Bright Light Therapy may cause eyestrain or headache. Since it involves exposure to intense light early in the day, it might also affect sleep patterns temporarily.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~15 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 15 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Hematuria
Body Weight Changes
Secondary study objectives
Inflammation
Inflammation

Trial Design

2Treatment groups
Experimental Treatment
Group I: No Bright Light Therapy via placebo glasses, Then Bright Light TherapyExperimental Treatment2 Interventions
Participants will wear their placebo device for 60 minutes every morning for 28-days (4 weeks)
Group II: Bright Light Therapy via ReTimer glasses, Then PlaceboExperimental Treatment2 Interventions
Participants will wear their device for 60 minutes every morning for 28-days (4 weeks)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bright Light Therapy
2010
Completed Early Phase 1
~60

Find a Location

Who is running the clinical trial?

Rush University Medical CenterLead Sponsor
439 Previous Clinical Trials
250,216 Total Patients Enrolled
Netanel ZilbersteinPrincipal InvestigatorRush University Medical Center
Ali Keshavarzian, M.D.Principal InvestigatorRush University Medical Center
1 Previous Clinical Trials
55 Total Patients Enrolled
Garth R Swanson, M.D.Principal InvestigatorMedical University of South Carolina

Media Library

Bright Light Therapy (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05579392 — N/A
Inflammatory Bowel Disease Research Study Groups: No Bright Light Therapy via placebo glasses, Then Bright Light Therapy, Bright Light Therapy via ReTimer glasses, Then Placebo
Inflammatory Bowel Disease Clinical Trial 2023: Bright Light Therapy Highlights & Side Effects. Trial Name: NCT05579392 — N/A
Bright Light Therapy (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05579392 — N/A
~4 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top